Premium
Bangalore-based Theramyt Novobiologics Pvt Ltd, which recently raised its first round of funding from various investors including Aarin Capital and Accel Partners, is on its way to develop a platform which couples drug design with development of unique product lines in oncology, rheumatoid arthritis and cardiovascular diseases, among others.“Theramyt’s focus ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
